ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,505.00
-0.71%
Dow Jones
40,287.53
0.00%
US Dollar vs MXN
18.0493
0.38%
Brent Oil
81.385
-1.09%
Bitcoin
67,580.47
-0.85%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
22/07/202407:30Business WireRegulatory Approval Obtained for Arch Insurance North America’s Acquisition of the U.S. MidCorp and Entertainment Businesses of AllianzNASDAQ:ACGLArch Capital Group Ltd
22/07/202407:30GlobeNewswire Inc.HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200NASDAQ:GMDAGamida Cell Ltd
22/07/202407:30GlobeNewswire Inc.Exela Technologies and AIDEO Technologies Enter Strategic AllianceNASDAQ:XELAExela Technologies Inc
22/07/202407:30Business WireAmbac to Release Second Quarter 2024 Results on August 5, 2024NYSE:AMBCAmbac Financial Group Inc
22/07/202407:30Business WireAmTrust Recognized as 2024 “Best and Brightest” Companies to Work For
22/07/202407:30GlobeNewswire Inc.Atossa Therapeutics Completes Enrollment of 80mg Pharmacokinetic Run-In Cohort in Phase 2 EVANGELINE Clinical Trial Evaluating (Z)-Endoxifen as a Neoadjuvant Treatment for ER+ / HER2- Breast CancerNASDAQ:ATOSAtossa Therapeutics Inc
22/07/202407:30GlobeNewswire Inc.RSports Interactive Acquires GameBlazers, a Next Generation Daily Fantasy Sports Gaming Company and Collectible Trading Platform
22/07/202407:30GlobeNewswire Inc.OTORIO's Midyear Report Reveals Alarming Trends and Proactive Strategies in OT-IoT-CPS Security
22/07/202407:29GlobeNewswire Inc.Willis Lease Finance Corporation Hires SR Technics Veteran, Caroline M. Vandedrinck, to Run its Growing Services BusinessesNASDAQ:WLFCWillis Lease Finance Corporation
22/07/202407:28Edgar (US Regulatory)Form 8-K - Current reportUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
22/07/202407:28PR Newswire (Canada)Corporation de Sécurité Garda World annonce une offre de billets de premier rang d'un montant principal global de 400 millions $ US échéant en 2032
22/07/202407:25Business WireTextron Aviation, al Farnborough International Airshow 2024, mostra i velivoli da addestramento multimotore per equipaggi militari di prossima generazioneNYSE:TXTTextron Inc
22/07/202407:23PR Newswire (Canada)goeasy Ltd. Announces Proposed Offering of US$150 Million of Senior Unsecured NotesTSX:GSYGoeasy Ltd
22/07/202407:22Crypto BriefingCrypto funds see $3.2 billion inflows in July amid bullish investor sentimentCOIN:FLOWUSDFlow
22/07/202407:22PR Newswire (Canada)goeasy Ltd. Announces Preliminary Second Quarter Selected DataTSX:GSYGoeasy Ltd
22/07/202407:20PR Newswire (US)EMPRESA NACIONAL DEL PETRÓLEO LAUNCHES ANY AND ALL CASH TENDER OFFER AND MAXIMUM TENDER OFFER FOR U.S. DOLLAR NOTES DUE 2026 AND 2031
22/07/202407:20PR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - JRVTSXV:JRVJervois Global Limited
22/07/202407:20PR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - SPAC.V
22/07/202407:18PR Newswire (Canada)Canadian Investment Regulatory Organization Trading Halt - JRVTSXV:JRVJervois Global Limited
22/07/202407:16Business WireAccenture to Acquire Camelot Management Consultants to Expand SAP and Supply Chain CapabilitiesNYSE:ACNAccenture Plc
22/07/202407:15PR Newswire (US)SilverSneakers Names Grayling Brown as 2024 Member of the Year, Celebrating Unwavering Dedication to Health, Fitness, and CommunityNASDAQ:TVTYTivity Health Inc
22/07/202407:15PR Newswire (US)KIRSTEN FLANIK JOINS REVOLT AS CEO, NORTH AMERICA
22/07/202407:15PR Newswire (Canada)Frontera Announces Agreement Between Puerto Bahia and GASCO To Pursue LPG Project in Cartagena, ColombiaTSX:FECFrontera Energy Corporation
22/07/202407:15PR Newswire (Canada)Canadian Investment Regulatory Organization Trading Halt - SPAC.V
22/07/202407:15PR Newswire (Canada)Blackwater Project - Removal of Non-Essential Personnel - Wildfire ResponseTSXV:ARTGArtemis Gold Inc
22/07/202407:13PR Newswire (US)Japan Airlines Will Modernize Fleet with up to 20 More Boeing 787 DreamlinersNYSE:BABoeing Co
22/07/202407:12PR Newswire (US)Cebu Pacific Celebrates Agreement for up to 152 A321neo Aircraft Order with Airbus, RTX's Pratt & WhitneyNYSE:RTXRTX Corporation
22/07/202407:11PR Newswire (US)Arkema CEO Thierry Le Henaff is the 2024 ICIS CEO of the Year
22/07/202407:10GlobeNewswire Inc.MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature – Scientific ReportsNASDAQ:MDXGMiMedx Group Inc
22/07/202407:10Business WireThe Seed Oil Free Alliance Welcomes Dr. Andrew Weil MD as Advisor, Medical Researcher and Partner

Su Consulta Reciente

AMEX
XLF
Financial Select Sector
FX
EURUSD
Euro vs US Dollar
COIN
BTCUSD
Bitcoin
NASDAQ
MSFT
Microsoft
COIN
SOLUSD
Solana
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
ADDYY
Adidas (QX)
CCOM
US500
US 500
NYSE
MCD
McDonalds
NYSE
VZ
Verizon Communications
NYSE
XOM
Exxon Mobil
NASDAQ
GOOGL
Alphabet
NYSE
DIS
Walt Disney
AMEX
XLE
Energy Select Sector SPDR
NYSE
CVX
Chevron
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados